Thomas Mika
physics
POET technologies
Singapore
Biography
Mika previously served as the Chairman of the Board of Rennova Health, the successor company to CollabRx and its predecessor, Tegal Corporation, a semiconductor capital equipment company. Since 2005, he has been the President and CEO, and at times the Acting Chief Financial Officer of CollabRx and Tegal, retaining those positions following its merger with Rennova Health in November 2015. Previously, Mika co-founded IMTEC, a boutique investment and consulting firm, serving clients in the U.S., Europe and Japan over a period of 20 years, taking on the role of CEO in several ventures. Earlier in his career, Mika was a managing consultant with Cresap, McCormick & Paget and a policy analyst for the National Science Foundation. He holds a Bachelor of Science in Microbiology from the University of Illinois at Urbana-Champaign and a Master of Business Administration from the Harvard Graduate School of Business.
Research Interest
science and technology
